La psychopharmacologie et les comorbidités médicales : Enjeux, défis et opportunités - Psychopharmacology and medical comorbidities: challenges and opportunities
Partagez cet événement
Achat de billets
Journée de Formation Médicale Continue ( 6 crédit approuvés FMSQ)
Titre : La psychopharmacologie et les comorbidités médicales
Enjeux, défis et opportunités
Publique cible :
- Psychiatres C-L (CACLP – société québécoise C-L – EAPSM)- Psychiatres généralistes- Résidents en psychiatrie et en médecine de famille- Pharmaciens- IPS- Étudiants en médecine
Le programme sera en mode hybride (en personne et en ligne)
Objectifs pédagogiques :
- Mieux connaître les défis et les traitements de la psychopathologie chez la population médicale- Incorporer les avancées récentes en psychopharmacologie dans la prise en charge de la population atteinte de conditions médicales chroniques.- Discuter à partir des situations cliniques les différents principes de psychopharmacologie.- Identifier des stratégies pour optimiser l’interdisciplinarité (rôles de IPS , pharmacien, psychiatre, médecins )
Programme
Le samedi 23 septembre 2023
8 :30 – 9 :00 : mot d’introduction et ouverture de la journée. Dr Pierre Verrier
09 :00- 10 h 15 : principes de la psychopharmacologie chez la population atteinte des conditions médicales chroniques. Dr James Levenson
10 :15 – 10h30 : période des questions
10 30 – 10 h 45 : pause santé
10h 45 – 11h45 : deuxième partie: Dr James Levenson
11h45 – midi : période des questions
12h00-13h00 : pause diner
Modérateurs : Dre Samah Ibrahim – Dr Alexandre Hudon
13h00 – 14h30 : présentation de vignettes cliniques et considérations éthiques : Dr James Levenson
14h30 – 14h 45 : période des questions
14h45 – 16h15 : Table ronde : stratégies pour optimiser l’interdisciplinarité (rôles de IPS, pharmaciens, psychiatres, médecins)
Participation d’équipes interdisciplinaires avec problématiques spécifiques
Cas complexes présentés par l’assemblée (chirurgie bariatrique – voie d’administration – Trauma crânien – Délirium – Dépression – Trouble à symptomatologie somatique – anxiété)
16h15 mot de la fin et fermeture de la journée. (Dr Leon Tourian )
-------------------------------------------------------------------------
Continuing Medical Education Symposium ( 6 CME units ) ( in English)
Title: Psychopharmacology and medical comorbidities: challenges and opportunities
Target audience:
- Consultation-liaison psychiatrists (CACLP – Québec society Consultation-liaison – EAPSM)
- General psychiatrists
- Residents in training (Psychiatry and family medicine residents).
- Pharmacists
- Specialized nurse practitioners
- Medical students
- Other mental health professionals
The program will be in hybrid mode (in person and online).
Learning objectives:
- Define the challenges and treatment of psychopathology in the medical population
- Apply recent advances in psychopharmacology in the care of the population with chronic medical conditions.
- Discuss, based on clinical situations, the different principles of psychopharmacology.
-Identify strategies to optimize interdisciplinarity (roles of a specialized nurse practitioner, pharmacist, psychiatrist, general practitioner)
Preliminary program ( Eastern Time Zone – Montréal)
Saturday, September 23, 2023
8:30 a.m. – 9:00 a.m.: Introductory remarks and opening of the day. Dr. Pierre Verrier
Moderators : Dr. Samah Ibrahim – Dr. Pierre Verrier
9:00-10:15: Principles of psychopharmacology in the population with chronic medical conditions. Dr James Levenson
10:15 a.m. – 10:30 a.m.: question period
10.30 a.m. – 10.45 a.m.: health break
10:45 a.m. – 11:45 a.m.: second part : Dr James Levenson
11:45 a.m. – noon: question period
12:00 p.m.-1:00 p.m.: lunch break
Moderators: Dr. Samah Ibrahim – Dr. Alexandre Hudon
1:00 p.m. – 2:30 p.m.: presentation of clinical vignettes and ethical considerations: Dr James Levenson
2:30 p.m. – 2:45 p.m.: question period
2:45 p.m. – 4:15 p.m.: Round table: strategies to optimize interdisciplinarity (roles of IPS, pharmacist, psychiatrist, medicine)
Participation of multidisciplinary team
Complex cases presented by the assembly (Bariatric surgery- different routes of administration- TBI – Delirium – Depression – Somatic symptomatology disorder – anxiety)
4:15 p.m. Closing remarks and closing of the day. (Dr. Leon Tourian)
Journée de Formation Médicale Continue ( 6 crédit approuvés FMSQ)
Titre : La psychopharmacologie et les comorbidités médicales
Enjeux, défis et opportunités
Publique cible :
- Psychiatres C-L (CACLP – société québécoise C-L – EAPSM)- Psychiatres généralistes- Résidents en psychiatrie et en médecine de famille- Pharmaciens- IPS- Étudiants en médecine
Le programme sera en mode hybride (en personne et en ligne)
Objectifs pédagogiques :
- Mieux connaître les défis et les traitements de la psychopathologie chez la population médicale- Incorporer les avancées récentes en psychopharmacologie dans la prise en charge de la population atteinte de conditions médicales chroniques.- Discuter à partir des situations cliniques les différents principes de psychopharmacologie.- Identifier des stratégies pour optimiser l’interdisciplinarité (rôles de IPS , pharmacien, psychiatre, médecins )
Programme
Le samedi 23 septembre 2023
8 :30 – 9 :00 : mot d’introduction et ouverture de la journée. Dr Pierre Verrier
09 :00- 10 h 15 : principes de la psychopharmacologie chez la population atteinte des conditions médicales chroniques. Dr James Levenson
10 :15 – 10h30 : période des questions
10 30 – 10 h 45 : pause santé
10h 45 – 11h45 : deuxième partie: Dr James Levenson
11h45 – midi : période des questions
12h00-13h00 : pause diner
Modérateurs : Dre Samah Ibrahim – Dr Alexandre Hudon
13h00 – 14h30 : présentation de vignettes cliniques et considérations éthiques : Dr James Levenson
14h30 – 14h 45 : période des questions
14h45 – 16h15 : Table ronde : stratégies pour optimiser l’interdisciplinarité (rôles de IPS, pharmaciens, psychiatres, médecins)
Participation d’équipes interdisciplinaires avec problématiques spécifiques
Cas complexes présentés par l’assemblée (chirurgie bariatrique – voie d’administration – Trauma crânien – Délirium – Dépression – Trouble à symptomatologie somatique – anxiété)
16h15 mot de la fin et fermeture de la journée. (Dr Leon Tourian )
-------------------------------------------------------------------------
Continuing Medical Education Symposium ( 6 CME units ) ( in English)
Title: Psychopharmacology and medical comorbidities: challenges and opportunities
Target audience:
- Consultation-liaison psychiatrists (CACLP – Québec society Consultation-liaison – EAPSM)
- General psychiatrists
- Residents in training (Psychiatry and family medicine residents).
- Pharmacists
- Specialized nurse practitioners
- Medical students
- Other mental health professionals
The program will be in hybrid mode (in person and online).
Learning objectives:
- Define the challenges and treatment of psychopathology in the medical population
- Apply recent advances in psychopharmacology in the care of the population with chronic medical conditions.
- Discuss, based on clinical situations, the different principles of psychopharmacology.
-Identify strategies to optimize interdisciplinarity (roles of a specialized nurse practitioner, pharmacist, psychiatrist, general practitioner)
Preliminary program ( Eastern Time Zone – Montréal)
Saturday, September 23, 2023
8:30 a.m. – 9:00 a.m.: Introductory remarks and opening of the day. Dr. Pierre Verrier
Moderators : Dr. Samah Ibrahim – Dr. Pierre Verrier
9:00-10:15: Principles of psychopharmacology in the population with chronic medical conditions. Dr James Levenson
10:15 a.m. – 10:30 a.m.: question period
10.30 a.m. – 10.45 a.m.: health break
10:45 a.m. – 11:45 a.m.: second part : Dr James Levenson
11:45 a.m. – noon: question period
12:00 p.m.-1:00 p.m.: lunch break
Moderators: Dr. Samah Ibrahim – Dr. Alexandre Hudon
1:00 p.m. – 2:30 p.m.: presentation of clinical vignettes and ethical considerations: Dr James Levenson
2:30 p.m. – 2:45 p.m.: question period
2:45 p.m. – 4:15 p.m.: Round table: strategies to optimize interdisciplinarity (roles of IPS, pharmacist, psychiatrist, medicine)
Participation of multidisciplinary team
Complex cases presented by the assembly (Bariatric surgery- different routes of administration- TBI – Delirium – Depression – Somatic symptomatology disorder – anxiety)
4:15 p.m. Closing remarks and closing of the day. (Dr. Leon Tourian)
Dr James Levenson
Dr. Levenson is the Rhona Arenstein Professor of Psychiatry, as well as Professor of Medicine and Surgery at the Virginia Commonwealth University School of Medicine, where he is also Chair, Division of Consultation-Liaison Psychiatry, and Vice-chair, Department of Psychiatry. He has published over 260 papers and book chapters, and ten books, including The American Psychiatric Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry, Clinical Manual of Psychopharmacology in the Medically Ill.
He is past president of the Academy of Consultation-Liaison Psychiatry. He served as the inaugural chair of the American Board of Psychiatry and Neurology’s Committee for Subspecialization in Consultation-Liaison Psychiatry from 2003-2018. He was a member of the DSM-5 and DSM-5-TR Work Groups on Somatic Symptom Disorders, and now serves on a DSM-5.1 committee. He is an editor emeritus of the Journal of Psychosomatic Research and is a member of its editorial board as well as Psychological Medicine. He has served on the National Board of Medical Examiners’ USMLE 3 Committee, and its Post-Licensure Assessment Committee. In his university’s health system, he has chaired the Ethics Committee for the past 34 years and has served on the boards of the Clinical Practice Plan, the Malpractice Plan, and the Health System’s Medicaid HMO. He has received his Medical School’s and his University’s highest teaching awards, as well as his Health System’s highest award as a clinician. He received the Thomas and Eleanor Hackett Award from the Academy of Consultation-Liaison Psychiatry, and a Lifetime Achievement Award from the Society for Liaison Psychiatry.
Dr. Levenson attended medical school at the University of Michigan, followed by internal medicine internship at the University of Oregon, psychiatric residency at the University of Colorado, and consultation-liaison psychiatry fellowship at Westchester County Medical Center. He is board-certified in Psychiatry and Consultation-Liaison Psychiatry.